NEOGENOMICS INC (NEO) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for NEOGENOMICS INC (NEO): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 30/100 — a percentile rank of NEOGENOMICS INC’s fundamentals against Services peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $2.3B |
| P / S | 3.0× |
| EV / EBITDA | 532.8× |
| Gross margin | 43.9% |
| Operating margin | -8.9% |
| Net margin | -6.8% |
| Return on equity | -6.6% |
| ROIC | -6.4% |
| Revenue growth | 11.2% |
| Debt / equity | 0.5× |
| Dividend yield | 0.0% |
Is NEOGENOMICS INC overvalued? P/S looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from NEOGENOMICS INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact